Alkermes Inc. plc
ALKS
Key stats
- Open
- 46.00
- Day high
- 48.30
- Day low
- 45.27
- Previous close
- 47.89
- Volume
- 3.13M
- VWAP
- 46.99
- 52-week high
- 55.67
- 52-week low
- 27.00
- Market cap
- 8.05B
- Shares out
- 168.04M
- Employees
- 2,050
- Listed
- 1991
About Alkermes Inc. plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
PHARMACEUTICAL PREPARATIONS · DUBLIN 4, L2 · alkermes.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 7.1K
- Put open interest
- 4.8K
- Put/call
- 0.68
- At-the-money IV
- 62.7%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 43 put | 2.55 | Oct 19, 1:59 PM | 187 | 248 | 64.6% |
| 48 put | 3.70 | Aug 18, 1:59 PM | 92 | 92 | 43.5% |
| 43 call | 3.19 | Oct 22, 12:38 PM | 50 | 158 | 86.2% |
| 55 put | 7.90 | Jul 28, 11:07 AM | 50 | 0 | — |
| 42 put | 1.50 | Oct 26, 1:56 PM | 12 | 402 | 75.7% |
| 37 put | 0.33 | Nov 2, 1:06 PM | 7 | 3.3K | 119.1% |
Quarterly results
Massive · Nov 3, 2026| Q3 2026 to Sep 30, 2026 | Q2 2026 to Jun 30, 2026 | Q1 2026 to Mar 31, 2026 | Q4 2025 to Dec 31, 2025 | |
|---|---|---|---|---|
| Revenue | $480.13M | $496.01M | $392.91M | $384.55M |
| Gross profit | $385.91M | $397.90M | $331.33M | $338.34M |
| Operating income | $36.02M | $18.35M | −$48.28M | $58.10M |
| Net income | $16.29M | $501.0K | −$66.48M | $49.34M |
| Diluted EPS | 0.09 | 0.00 | -0.40 | 0.29 |
| Operating cash flow | $93.48M | $145.18M | −$165.74M | $170.07M |
| Assets | $4.44B | $4.39B | $4.26B | $2.49B |
| Liabilities | $2.57B | $2.58B | $2.51B | $667.70M |
| Equity | $1.86B | $1.81B | $1.75B | $1.82B |
Technicals
Massive · Nov 12, 2026- 50-day average43.67
- 200-day average41.06
- RSI (14 days)61.6
Short interest
Massive · Oct 30, 2026- Oct 30, 202619.65M shares · 11.3 days to cover
- Oct 15, 202619.05M shares · 9.1 days to cover
- Sep 30, 202617.82M shares · 6.3 days to cover
- Sep 15, 202615.16M shares · 10.7 days to cover
Related companies
MassiveNews coverage
No stories about Alkermes Inc. plc right now.